Danaher | DHR - Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 2.94M 2026-03
Agilent USD 281.97M 252K 2026-06
Align Technology USD 71.62M 1000 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Bruker USD 152.35M 130K 2026-06
Charles River Laboratories USD 47.73M 439K 2026-06
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
ESCO Technologies USD 25.91M 11K 2026-03
Fortive USD 302.6M 3M 2026-06
Henry Schein USD 111.92M 2.51M 2026-06
Illumina USD 151.3M 607K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Keysight Technologies USD 170.3M 700K 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Medtronic USD 1.28B 130K 2026-06
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Quest Diagnostics USD 110M 1000K 2026-06
Quidel USD 68.1M 200K 2026-03
Repligen USD 56.43M 28K 2026-06
Revvity USD 111.63M 174K 2026-06
Roper Industries USD 98.9M 3.5M 2026-06
Stryker USD 383.4M 416K 2026-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Waters USD 98.19M 20K 2026-06
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06